Latest Earnings Results: Q3 '26
Estimated EPS
$0.08
Reported EPS
---
Surprise
---
Estimated Rev
$80.04M
Reported Rev
$87.83M
Surprise
+9.74%
• Reported GAAP EPS of $0.09 up 137.50% YoY • Reported revenue of $87.83M up 43.12% YoY • For the year ending December 31, 2026, Omada Health expects revenue in the range of $334 million to $340 million and adjusted EBITDA in the range of $21 million to $27 million.
Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q3 '26 | $0.08 | -- | -- | N/A |
Q2 '26 | $0.06 | -- | -- | N/A |
Q1 '26 | -$0.13 | $0.04 | 131.04% | BEAT |
Q4 '25 | $0.01 | $0.08 | 840.18% | BEAT |
Q3 '25 | -$0.08 | -$0.06 | 24.03% | BEAT |